TY  - JOUR
AU  - Dojčilović, Radovan
AU  - Pajović, Jelena D.
AU  - Božanić, Dušan K.
AU  - Jović, Nataša
AU  - Pavlović, Vera P.
AU  - Pavlović, Vladimir
AU  - Lenhardt-Acković, Lea
AU  - Zeković, Ivana
AU  - Dramicanin, Miroslav D.
AU  - Kascakova, Slavka
AU  - Refregiers, Matthieu
AU  - Rasić, Goran
AU  - Vlahović, Branislav
AU  - Djoković, Vladimir
PY  - 2018
UR  - http://aspace.agrif.bg.ac.rs/handle/123456789/4655
AB  - The interaction of partially reduced graphene oxide (prGO) and Huh7.5.1 liver cancer cells was investigated by means of DUV fluorescence bioimaging. The prGO sample was obtained by the reduction (to a certain extent) of the initially prepared graphene oxide (GO) nanosheets with hydrazine. The fluorescence of the GO nanosheets increases with time of the reduction due to a change in ratio of the sp(2) and sp(3) carbon sites and the prGO sample was extracted from the dispersion after 6 min, when the intensity of the fluorescence reached its maximum. The reduction process was left to proceed further to saturation until highly reduced graphene oxide (denoted here as rGO) was obtained. GO, prGO and rGO samples were investigated by structural (scanning electron microscopy (SEM), scanning transmission electron microscopy coupled with energy dispersive spectrometry (STEM-EDS)) and spectroscopic (UV-vis, photoluminescence (PL), Raman) methods. After that, Huh7.5.1 cells were incubated with GO, prGO and rGO nanosheets and used in bioimaging studies, which were performed on DISCO beamline of synchrotron SOLEIL. It was found that the prGO significantly enhanced the fluorescence of the cells and increased the intensity of the signal by similar to 2.5 times. Time-lapse fluorescence microscopy experiments showed that fluorescence dynamics strongly depends on the type of nanosheets used. The obtained prGO nanostructure can be easily conjugated with aromatic ring containing drugs, which opens a possibility for its applications in fluorescence microscopy monitored drug delivery.
PB  - IOP Publishing Ltd, Bristol
T2  - 2d Materials
T1  - DUV fluorescence bioimaging study of the interaction of partially reduced graphene oxide and liver cancer cells
IS  - 4
VL  - 5
DO  - 10.1088/2053-1583/aad72b
ER  - 

@article{
author = "Dojčilović, Radovan and Pajović, Jelena D. and Božanić, Dušan K. and Jović, Nataša and Pavlović, Vera P. and Pavlović, Vladimir and Lenhardt-Acković, Lea and Zeković, Ivana and Dramicanin, Miroslav D. and Kascakova, Slavka and Refregiers, Matthieu and Rasić, Goran and Vlahović, Branislav and Djoković, Vladimir",
year = "2018",
abstract = "The interaction of partially reduced graphene oxide (prGO) and Huh7.5.1 liver cancer cells was investigated by means of DUV fluorescence bioimaging. The prGO sample was obtained by the reduction (to a certain extent) of the initially prepared graphene oxide (GO) nanosheets with hydrazine. The fluorescence of the GO nanosheets increases with time of the reduction due to a change in ratio of the sp(2) and sp(3) carbon sites and the prGO sample was extracted from the dispersion after 6 min, when the intensity of the fluorescence reached its maximum. The reduction process was left to proceed further to saturation until highly reduced graphene oxide (denoted here as rGO) was obtained. GO, prGO and rGO samples were investigated by structural (scanning electron microscopy (SEM), scanning transmission electron microscopy coupled with energy dispersive spectrometry (STEM-EDS)) and spectroscopic (UV-vis, photoluminescence (PL), Raman) methods. After that, Huh7.5.1 cells were incubated with GO, prGO and rGO nanosheets and used in bioimaging studies, which were performed on DISCO beamline of synchrotron SOLEIL. It was found that the prGO significantly enhanced the fluorescence of the cells and increased the intensity of the signal by similar to 2.5 times. Time-lapse fluorescence microscopy experiments showed that fluorescence dynamics strongly depends on the type of nanosheets used. The obtained prGO nanostructure can be easily conjugated with aromatic ring containing drugs, which opens a possibility for its applications in fluorescence microscopy monitored drug delivery.",
publisher = "IOP Publishing Ltd, Bristol",
journal = "2d Materials",
title = "DUV fluorescence bioimaging study of the interaction of partially reduced graphene oxide and liver cancer cells",
number = "4",
volume = "5",
doi = "10.1088/2053-1583/aad72b"
}

Dojčilović, R., Pajović, J. D., Božanić, D. K., Jović, N., Pavlović, V. P., Pavlović, V., Lenhardt-Acković, L., Zeković, I., Dramicanin, M. D., Kascakova, S., Refregiers, M., Rasić, G., Vlahović, B.,& Djoković, V.. (2018). DUV fluorescence bioimaging study of the interaction of partially reduced graphene oxide and liver cancer cells. in 2d Materials
IOP Publishing Ltd, Bristol., 5(4).
https://doi.org/10.1088/2053-1583/aad72b

Dojčilović R, Pajović JD, Božanić DK, Jović N, Pavlović VP, Pavlović V, Lenhardt-Acković L, Zeković I, Dramicanin MD, Kascakova S, Refregiers M, Rasić G, Vlahović B, Djoković V. DUV fluorescence bioimaging study of the interaction of partially reduced graphene oxide and liver cancer cells. in 2d Materials. 2018;5(4).
doi:10.1088/2053-1583/aad72b .

Dojčilović, Radovan, Pajović, Jelena D., Božanić, Dušan K., Jović, Nataša, Pavlović, Vera P., Pavlović, Vladimir, Lenhardt-Acković, Lea, Zeković, Ivana, Dramicanin, Miroslav D., Kascakova, Slavka, Refregiers, Matthieu, Rasić, Goran, Vlahović, Branislav, Djoković, Vladimir, "DUV fluorescence bioimaging study of the interaction of partially reduced graphene oxide and liver cancer cells" in 2d Materials, 5, no. 4 (2018),
https://doi.org/10.1088/2053-1583/aad72b . .